Vance cautioned that the role of prophylaxis for P. carinii pneumochial biopsies) were completely negative, and the patient was connia (PCP) should be reexamined for patients who are receiving sidered to be in complete remission. No relapse of PCP has been sequential high doses of chemotherapy with stem cell support and observed while PCP prophylaxis was continued (as of a 16-month who may be at increased risk for PCP. These authors made this follow-up examination). recommendation after two of their patients with breast cancer deOur HIV-negative patient, who had not had previous exposure veloped PCP. The accompanying editorial clearly warned that less to corticosteroids, developed documented PCP after a single cycle than acute awareness of P. carinii, a versatile opportunist with a of low-dose cytotoxic chemotherapy for local relapse of breast propensity for ''sneak attacks,'' can have disastrous results. Defincancer. In their review of PCP in patients with breast cancer (24 ing the risk of PCP among immunocompromised patients, includcases), Kulke and Vance [1] stressed that most of the patients had ing risk assessment for PCP in these individuals, and keeping up received prolonged corticosteroid therapy. The two patients they with newly emerging information about P. carinii are, as the editodescribed had not received steroids, but these patients were receivrial states, essential [2] . ing high-dose chemotherapy and had severe CD4 T cell lymphocyOur own studies, which began in 1973 and involved the assesstopenia at the time PCP was diagnosed. ment of titers of P. carinii antigen and antibody in patients with According to Walzer [2], it is not the nature of the underlying bone marrow transplants [4], renal allografts [5] , and a wide variety disorder that predisposes to the development of PCP in patients of malignancies [6] , demonstrated the threat of P. carinii among with cancer, but rather the type and the intensity of the cytotoxic such patients. Similar findings were observed in a study of patients or immunosuppressive therapy used to treat the cancer. However, with HIV-1 infection and either specimen-documented or clinically other potential contributing factors deserve to be studied. Sepkodiagnosed P. carinii infections. This was demonstrated by a frewitz et al. [3] suggested that patients who had received previous quently lengthy period of antigenemia before the onset of pneumoradiation therapy to the thorax might be at higher risk of developing nia and a decline in antigen titer after the initiation of specific PCP. Among the 24 cases of PCP in patients with breast cancer therapy for PCP [7] . reviewed by Kulke and Vance [1], the only patient who clearly
Twenty days later, the patient's cough and shortness of breath relapsed, without fever. Examination of specimens, including BAL fluid obtained by fiberoptic bronchoscopy, did not reveal P. carinii, Pneumocystis carinii: A Versatile Opportunist but histological studies of a transbronchial biopsy specimen revealed lymphangitic carcinomatosis of the lung. She subsequently SIR-An original paper by Kulke and Vance [1] , an editorial received eight cycles of high-dose chemotherapy, which included response by Walzer in the same issue of Clinical Infectious Discyclophosphamide, doxorubicin, 5-fluorouracil, and vindesine, and eases (CID) [2] , and a brief report by Heresi et al. [3] in CID have her respiratory symptoms resolved. After six cycles, the results of once again focused attention on Pneumocystis carinii. Kulke and several studies (including fiberoptic bronchoscopy with transbronVance cautioned that the role of prophylaxis for P. carinii pneumochial biopsies) were completely negative, and the patient was connia (PCP) should be reexamined for patients who are receiving sidered to be in complete remission. No relapse of PCP has been sequential high doses of chemotherapy with stem cell support and observed while PCP prophylaxis was continued (as of a 16-month who may be at increased risk for PCP. These authors made this follow-up examination). recommendation after two of their patients with breast cancer deOur HIV-negative patient, who had not had previous exposure veloped PCP. The accompanying editorial clearly warned that less to corticosteroids, developed documented PCP after a single cycle than acute awareness of P. carinii, a versatile opportunist with a of low-dose cytotoxic chemotherapy for local relapse of breast propensity for ''sneak attacks,'' can have disastrous results. Defincancer. In their review of PCP in patients with breast cancer (24 ing the risk of PCP among immunocompromised patients, includcases), Kulke and Vance [1] stressed that most of the patients had ing risk assessment for PCP in these individuals, and keeping up received prolonged corticosteroid therapy. The two patients they with newly emerging information about P. carinii are, as the editodescribed had not received steroids, but these patients were receivrial states, essential [2] . ing high-dose chemotherapy and had severe CD4 T cell lymphocyOur own studies, which began in 1973 and involved the assesstopenia at the time PCP was diagnosed.
ment of titers of P. carinii antigen and antibody in patients with According to Walzer [2] , it is not the nature of the underlying bone marrow transplants [4] , renal allografts [5] , and a wide variety disorder that predisposes to the development of PCP in patients of malignancies [6] , demonstrated the threat of P. carinii among with cancer, but rather the type and the intensity of the cytotoxic such patients. Similar findings were observed in a study of patients or immunosuppressive therapy used to treat the cancer. However, with HIV-1 infection and either specimen-documented or clinically other potential contributing factors deserve to be studied. Sepkodiagnosed P. carinii infections. This was demonstrated by a frewitz et al. [3] suggested that patients who had received previous quently lengthy period of antigenemia before the onset of pneumoradiation therapy to the thorax might be at higher risk of developing nia and a decline in antigen titer after the initiation of specific PCP. Among the 24 cases of PCP in patients with breast cancer therapy for PCP [7] . reviewed by Kulke and Vance [1] , the only patient who clearly
In view of these data and other references too numerous to cite did not receive steroid therapy before infection developed had in a correspondence, it is not surprising that Heresi et al. [3] have concurrent lymphangitic carcinomatosis. In the case reported documented severe PCP in infants exposed to HIV-1 who were herein, neither the single cycle of low-dose chemotherapy nor the nonetheless negative for the virus. The most provocative question CD4 cell count would be sufficient to explain the development of concerns the possibility that P. carinii could, like Toxoplasma PCP. We suggest that local factors such as previous irradiation or gondii, have been transmitted in utero. In a laboratory rat model the presence of lymphangitic carcinomatosis could be additional of PCP, in utero transmission was shown to be a distinct possibility risk factors for PCP in patients with breast cancer. [8] . P. carinii has been detected in bone marrow and rectal biopsy specimens as well as the retina, pancreas, spleen, inner ear, and Pierre Tattevin, Mario Di Palma, and Daniel Vittecoq CNS of HIV-1-positive individuals [9] . Would in utero transmis- Alternatively, close contact between a mother and a neonate would also constitute ideal conditions for horizontal transmission of P. cariReferences nii. It has been known for years that healthy children and adults have substantial titers of antibody to P. carinii [9] and that P. carinii 17 individuals with specimen-documented PCP [11] .
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In summary, studies have demonstrated that P. carinii may not only antibiotic therapy actually examined in controlled studies and shown to prevent rheumatic fever is penicillin. Chlortetracycline have been sufficiently considered for patients whose common feature is immunosuppression due to a variety of reasons, including [2] and oxytetracycline [3] were evaluated in clinical trials of sufficient size to determine their effectiveness in preventing rheutherapy for malignancy and organ transplantation. Although the prevalence of PCP among HIV-1-positive individuals has rematic fever. A significant reduction in the number of cases of rheumatic fever was demonstrated with chlortetracycline treatceived more attention, it is clear that heightened awareness of the possibility of PCP in any significantly immunosuppressed patient ment, while the reduction with oxytetracycline treatment was borderline (P Å .07). would be prudent. Without question, further research will be essential to provide more in-depth fundamental information about the Perhaps the authors meant to say that of currently recommended antibiotics, penicillin is the only one that has been evaluated in nature of this intriguing opportunist.
clinical trials. The criterion for choosing other antibiotics is a high rate of eradication of the infecting organism. My colleagues and Linda L. Williford Pifer I observed in our paper on chlortetracycline that eradication of the 
